Tzofen Overview
- Year Founded
-
2018

- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
1
Tzofen General Information
Description
Developer of a novel biological platform designed to facilitate the treatment of various cancer types. The company's platform shows the ability to eliminate cancer growth in-vitro and in-vivo, enabling users to save millions of people's lives.
Contact Information
Website
www.tzofen-bt.comCorporate Office
- Tel Aviv
- Israel
Corporate Office
- Tel Aviv
- Israel
Tzofen Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
1. Accelerator/Incubator | 25-Mar-2020 | Completed | Pre-Clinical Trials |
Tzofen Investors (1)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
MassChallenge | Accelerator/Incubator |
Tzofen FAQs
-
When was Tzofen founded?
Tzofen was founded in 2018.
-
Where is Tzofen headquartered?
Tzofen is headquartered in Tel Aviv, Israel.
-
What industry is Tzofen in?
Tzofen’s primary industry is Drug Discovery.
-
Is Tzofen a private or public company?
Tzofen is a Private company.
-
What is Tzofen’s current revenue?
The current revenue for Tzofen is
. -
Who are Tzofen’s investors?
MassChallenge has invested in Tzofen.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »